SWOG clinical trial number
SWOG-8916

Evaluation of Merbarone in Pancreatic Adenocarcinoma

Closed
Phase
Accrual
86%
Published
Abbreviated Title
Evaluation of Merbarone in Pancreatic Adenocarcinoma
Activated
03/15/1990
Closed
06/15/1991

Publication Information Expand/Collapse

2014

Historical controls for metastatic pancreatic cancer: benchmarks for planning and analyzing single arm phase II trials

PA Philip;K Chansky;L Rubenstein;M Leblanc;L Seymour;SP Ivy;SR Alberts;PJ Catalano;J Crowley Clinical Cancer Research 20(16):4176-4185;

PMid: PMID24914040 | PMC number: PMC4296727

1993

Phase II trial of merbarone in pancreatic carcinoma: A Southwest Oncology Group study.

EH Kraut;T Fleming;JS Macdonald;CH Spiridonidis;JE Bradof;LH Baker AJCO 16(4):327-328